| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
IGM Biosciences, Inc.
13D/A
IGMS · 449585108
|
0% |
8/18/2025
Event 8/14/2025
|
||||
| Topsoe Holding A/S | 0% | |||||
| Jakob Haldor Topsoe | 0% | |||||
| Christina Teng Topsoe | 0% | |||||
| Anne Haugwitz-Hardenberg-Reventlow | 0% | |||||
| Emil Oigaard | 0% | |||||
| Thomas Schleicher | 0% | |||||
| Birgitte Nielsen | 0% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.